Homeostatic control of angiogenesis: A newly identified function of the liver?

Hepatology

Volumn 29, Issue 3, 1999, Pages 621-623

  Clément, Bruno ^a   Musso, Orlando ^a   Liétard, Jocelyne ^a   Théret, Nathalie ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; COLLAGEN; ENDOSTATIN; PLASMINOGEN;

ANGIOGENESIS; APOPTOSIS; CANCER; ENDOTHELIUM CELL; HUMAN; LIVER; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033019263     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290341     Document Type: Review

References (14)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? Natl Cancer Inst 1990;82:4-6.
2. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991;52:217-239.
3. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991;66:1095-1104.
4. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
5. Cockerill GW, Gamble JR, Vadas MA. Angiogenesis: models and modulators. Int Rev Cytol 1995;159:113-160.
6. Sage EH. Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol 1997;7:182-186.
7. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993;73:161-195.
8. Clément B, Grimaud JA, Campion JP, Deugnier Y, Guillouzo A. Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. HEPATOLOGY 1986;6:225-234.
9. Homandberg GA, Williams JE, Grant D, Schumacher B, Eisenstein R. Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. Am J Pathol 1985;120:327-332.
10. Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, et al. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci U S A 1997;94:10868-10872.
11. Lijnen HR, Ugwu F, Bini A, Collen D. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 1998;37:4699-4702.
12. Dong Z, Kumar R, Yang X, Fidler IJ. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997;88:801-810.
13. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79: 315-328.
14. Gately S, Twardowski P, Stack MS, Patrick M, Boggio L, Cundiff DL, Schnaper HW, et al. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor angiostatin. Cancer Res 1996;56:4887-4890.